BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Argos Therapeutics, Inc. (Formerly Merix Bioscience) 

4233 Technology Drive

Durham  North Carolina  27704  U.S.A.
Phone: 919-287-6300 Fax: 919-287-6301


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology


Collaborations

Duke University  Exclusive license to the RNA based vaccine technology.

Rockefeller University  Exclusive worldwide rights to technology developed at Rockefeller relating to generation of dendritic cells.

Baylor University  Clinical and preclinical research in Lupus.

Kirin Brewery Co., Ltd.  The companies will collaborate to develop and commercialize dendritic cell vaccines, initially in the areas of cancer and infectious diseases.

Erlangen University  Clinical and preclinical research in Melanoma.





 Company News
Argos Therapeutics, Inc. (ARGS) Announces Filing Of Its Annual Report On Form 10-K 4/8/2014 7:41:05 AM    More...
Argos Therapeutics, Inc. (ARGS) To Present At The 13th Annual Needham Healthcare Conference 4/2/2014 9:02:20 AM    More...
Argos Therapeutics, Inc. (ARGS) Added To Russell 2000® And 3000® Indexes 4/1/2014 9:13:44 AM    More...
Argos Therapeutics, Inc. (ARGS) Reports Fourth Quarter And Year-End 2013 Financial Results 3/28/2014 8:00:51 AM    More...
Argos Therapeutics, Inc. (ARGS) To Present At 21st Annual Future Leaders In The Biotech Industry Conference 3/21/2014 9:06:53 AM    More...
Argos Therapeutics, Inc. (ARGS) To Present At Regenerative Medicine And Cancer Immunotherapy Meetings 3/20/2014 9:18:22 AM    More...
Argos Therapeutics, Inc. (ARGS) To Present At The 2nd Annual Sachs Cancer Bio Partnering & Investment Forum 3/17/2014 9:12:31 AM    More...
Argos Therapeutics, Inc. (ARGS)To Hold Fourth Quarter And Year End 2013 Financial Results Conference Call On Thursday, March 27, 2014 3/17/2014 8:48:42 AM    More...
Argos Therapeutics, Inc. (ARGS) Presents New Data From Clinical Research For AGS-004 Patient-Specific Immunotherapy In Treatment Of HIV 3/5/2014 9:08:21 AM    More...
Forbion Announces Closing Of Public Offering Of Portfolio Company, Argos Therapeutics, Inc. (ARGS) 2/20/2014 8:45:47 AM    More...
12345678910...